rs2275220
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004523.4(KIF11):c.699-91A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.038 in 700,048 control chromosomes in the GnomAD database, including 639 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 138 hom., cov: 32)
Exomes 𝑓: 0.039 ( 501 hom. )
Consequence
KIF11
NM_004523.4 intron
NM_004523.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.306
Publications
5 publications found
Genes affected
KIF11 (HGNC:6388): (kinesin family member 11) This gene encodes a motor protein that belongs to the kinesin-like protein family. Members of this protein family are known to be involved in various kinds of spindle dynamics. The function of this gene product includes chromosome positioning, centrosome separation and establishing a bipolar spindle during cell mitosis. [provided by RefSeq, Jul 2008]
KIF11 Gene-Disease associations (from GenCC):
- ciliopathyInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- microcephaly with or without chorioretinopathy, lymphedema, or intellectual disabilityInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-92612949-A-G is Benign according to our data. Variant chr10-92612949-A-G is described in ClinVar as Benign. ClinVar VariationId is 1245602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0571 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0338 AC: 5141AN: 152084Hom.: 138 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5141
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0392 AC: 21454AN: 547846Hom.: 501 AF XY: 0.0376 AC XY: 10848AN XY: 288894 show subpopulations
GnomAD4 exome
AF:
AC:
21454
AN:
547846
Hom.:
AF XY:
AC XY:
10848
AN XY:
288894
show subpopulations
African (AFR)
AF:
AC:
143
AN:
14276
American (AMR)
AF:
AC:
1638
AN:
21580
Ashkenazi Jewish (ASJ)
AF:
AC:
205
AN:
14776
East Asian (EAS)
AF:
AC:
814
AN:
32340
South Asian (SAS)
AF:
AC:
825
AN:
46556
European-Finnish (FIN)
AF:
AC:
3555
AN:
44882
Middle Eastern (MID)
AF:
AC:
13
AN:
2316
European-Non Finnish (NFE)
AF:
AC:
13249
AN:
342098
Other (OTH)
AF:
AC:
1012
AN:
29022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
991
1982
2973
3964
4955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0338 AC: 5139AN: 152202Hom.: 138 Cov.: 32 AF XY: 0.0357 AC XY: 2655AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
5139
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
2655
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
377
AN:
41536
American (AMR)
AF:
AC:
922
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
38
AN:
3468
East Asian (EAS)
AF:
AC:
159
AN:
5178
South Asian (SAS)
AF:
AC:
72
AN:
4820
European-Finnish (FIN)
AF:
AC:
863
AN:
10590
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2641
AN:
68012
Other (OTH)
AF:
AC:
47
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
249
498
748
997
1246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
89
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.